[1] |
Morita K, Taketomi A, Soejima Y, et al. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation. Liver Transpl, 2009; 15, 1412−6. doi: 10.1002/lt.21894 |
[2] |
Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol, 2009; 10, 35−43. doi: 10.1016/S1470-2045(08)70284-5 |
[3] |
Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001; 33, 1394−403. doi: 10.1053/jhep.2001.24563 |
[4] |
Al-Joundi T, Gibson S, Brunt EM, et al. Delayed recurrence of hepatocellular carcinoma after liver transplantation: detection of origin by chromosomal analysis. Liver Transpl, 2000; 6, 374−5. doi: 10.1053/lv.2000.5202 |
[5] |
Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol, 2005; 14, 34−8. doi: 10.1097/01.pas.0000143609.85487.36 |
[6] |
Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature, 2009; 458, 719−24. doi: 10.1038/nature07943 |
[7] |
Huang J, Deng Q, Wang Q, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet, 2012; 44, 1117−21. doi: 10.1038/ng.2391 |
[8] |
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 2010; 26, 589−95. doi: 10.1093/bioinformatics/btp698 |
[9] |
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 2010; 38, e164. doi: 10.1093/nar/gkq603 |
[10] |
Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet, 2011; 43, 828−9. doi: 10.1038/ng.903 |